Trials / Completed
CompletedNCT05534659
Comparison of Programmable and Non-programmable CSF Shunts Among Adult Hydrocephalus Patients With Different Etiologies
Comparison of Benefit and Survival for Different Etiologies of Adult Patients With Hydrocephalus Between Programmable Cerebrospinal Fluid Ventricular Shunt and Non-programmable Cerebrospinal Fluid Ventricular Shunt
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 325 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Programmable valve (PV) has been shown as a solution to the high revision rate in pediatric hydrocephalus patients, but it remains controversial among adults. This study is to compare the overall revision rate, revision cause, and revision-free survival between PV and non-programmable valve (NPV) in adult patients with different hydrocephalus etiologies.
Detailed description
Relatively high revision rates up to 32% of CSF shunting operations remained an unsolved problem for neurosurgeons. The cause of revisions were diverse, including overdrainage/underdrainage, shunting system obstruction, infection or technical skill related. Programmable valve (PV) has been shown as a solution to the high revision rate in pediatric hydrocephalus patients, but it remains controversial among adults. This study is to compare the overall revision rate, revision cause, and revision-free survival between PV and non-programmable valve (NPV) in adult patients with different hydrocephalus etiologies. The investigators reviewed the chart of all patients with hydrocephalus receiving index ventricular CSF shunt operations conducted at a single institution in northern Taiwan from January 2017 to December 2017. Patients included in the study were followed up for at least five years. Statistical tests including independent t-test, Chi-square test and Fisher's exact test were used for comparative analysis, and Kaplan-Meier curve using log-rank test was performed to compare the revision-free survival between the PV and NPV groups
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Programmable valve | Programmable valve used in the study included Medtronic Strata, B-Braun ProGav, Codman Certas. |
| DEVICE | Non-programmable valve | Non-programmable valve used in the study was Medtronic CSF-flow control valve. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2022-03-01
- Completion
- 2022-07-31
- First posted
- 2022-09-09
- Last updated
- 2022-09-16
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05534659. Inclusion in this directory is not an endorsement.